Conduct of Research Collaboration. (i) On or about August 1, 2002, Gilead will, at its own expense, supply to Anadys the quantities of the Target set forth in the Work Plan and the Library Compounds, as selected by Gilead. Anadys will diligently use its screen development and assay validation capabilities to develop two (2) validated screening assays for use with ATLAS for the Target (each, a "TARGET ASSAY") pursuant to the Work Plan. One Target Assay will be for use with [...***...] and one Target Assay will be for use with no [...***...
Conduct of Research Collaboration. Each Party:
(a) shall conduct its responsibilities under the Research Collaboration, as assigned to it under the Research Collaboration Plan and shall use Commercially Reasonable Efforts to achieve the objectives and timelines within the Research Collaboration Plan;
(b) shall conduct the Research Collaboration in compliance with all Applicable Laws; and
(c) may utilize the services of its Affiliates and Third Parties to perform those activities assigned to it under the Research Collaboration, subject to Section 3.2 below.
Conduct of Research Collaboration. During the term of the Research Collaboration, each Party shall:
2.6.1 undertake its obligations under the Research Collaboration as set forth in the Research Plan, provided however that any changes or adjustments in the allocation of CRL resources to the gp120 Target research program and/or the gp41 Target research program or within such programs as recommended by the JRC be made in accordance with the provisions outlined in Section 2.7.2 and ARTICLE 3, such adjustments to fall within the specific CRL resource allocation specified therein;
2.6.2 use all reasonable efforts and proceed diligently to perform the work set out for such Party to perform the Research Plan, including without limitation by using personnel with such sufficient skills and experience, together with sufficient equipment and facilities to perform its obligations under the Research Plan;
2.6.3 conduct the Research Plan in good scientific manner and in compliance in all material respects with the requirements of applicable laws, rules and regulations, and all other requirements of any applicable good laboratory practices to attempt to achieve its objectives efficiently and expeditiously;
2.6.4 within thirty (30) days following the end of each calendar month during the first six months of the term of the Research Collaboration furnish the other Party with a reasonably detailed written report summarizing the activities conducted by such Party under the Research Plan during such month; and
2.6.5 provide reasonable and informal access to, and communication with, any and all of such Party’s FTEs assigned to the Research Collaboration, as well as to records pertaining to research activities under the Research Plan on a need-to-know basis and in accordance with Section 2.10 herein.
Conduct of Research Collaboration. 5.6 Visitation.................................................... 5.7
Conduct of Research Collaboration. During the term of the Research Collaboration, each party shall:
(a) undertake an interactive, cooperative Research Collaboration with the other party as set forth in any Annual Research Plan, and such other activities which, from time to time, the Research Steering Committee decides are necessary for the commercial success of the Research Collaboration;
(b) use all reasonable efforts and proceed diligently to perform the work set out for such party to perform in each Annual Research Plan, including, without limitation, by using personnel with sufficient skills and experience, together with sufficient equipment and facilities, to carry out such party's obligations under the Research Collaboration and to accomplish the objectives of the Research Collaboration;
(c) conduct the Research Collaboration in good scientific manner, and in compliance in all material respects with all requirements of applicable laws, rules and regulations, and all other requirements of any applicable good laboratory practices to attempt to achieve its objectives efficiently and expeditiously;
(d) within 30 days following the end of each quarter during the term of the Research Collaboration, furnish the RSC with written reports summarizing all activities conducted by such party under the Research Collaboration during such quarter, including without limitation: (i) with respect to Pharmacopeia, all data and information regarding Collaboration *** Information omitted and filed separately with the Commission under Rule 24b-2. Compounds, structures thereof and biological assays developed by Pharmacopeia relating to the Field, provided, that it is understood that Pharmacopeia shall have no obligation to disclose to BMS any Excluded Technology, and further provided, that Pharmacopeia shall not be obligated to disclose any data or information regarding Collaboration Compounds that have been previously licensed by Pharmacopeia to a third party; and (ii) with respect to BMS, all data and information regarding Collaboration Compounds, structures thereof and biological assays developed by BMS relating to the Field which would be useful for the Research Collaboration;
(e) within 30 days following the end of each six-month period during the term of the Research Collaboration and within 30 days following the expiration or termination of the Research Collaboration, furnish the other party with reasonably detailed, written reports on all activities conducted by such party under the Research Collabor...
Conduct of Research Collaboration. During the Collaboration Term and under the direction and supervision of the RCMC, each Party shall (a) perform or cause to be performed its obligations under the Research Plan in good scientific manner and in compliance in all material aspects with all Applicable Law, including, unless otherwise set forth in the Research Plan, good laboratory practices and good clinical practices, and (b) allocate the time, effort, equipment and skilled personnel to complete such activities as set forth in the Research Plan. Following the Effective Date, the Parties shall promptly commence the Research Collaboration. Avanir undertakes insofar as it relates to animal care in the activities to be carried out by it hereunder to comply with the AAALAC standards and shall use its best reasonable efforts to comply with the AstraZeneca International Policy on Animal Care and Use to the extent stricter than the AAALAC standards.
Conduct of Research Collaboration. During the Collaboration Term and under the direction and supervision of the CMC, each Party shall (a) perform or cause to be performed its obligations under the Research Plan in good scientific manner and in compliance in all relevant material aspects with all Applicable Law, including, as required by the Research Plan, good laboratory practices, good manufacturing practice and good clinical practices, (b) allocate sufficient time, effort, equipment and skilled personnel to complete such activities successfully and promptly and (c) insofar as the activities involve the use of animals by Palatin, Palatin shall conduct activities in accordance with the AAALAC standards and AstraZeneca International Policy on Animal Care and Use, attached hereto as Schedule 3.1, to the extent stricter than the AAALAC standards. Following the Effective Date, the Parties shall promptly commence the Research Collaboration.
Conduct of Research Collaboration. Except as contemplated by the Research Plan, the Research will be conducted by LKS at LKS's laboratories or such other sites approved by the CMC. LKS will use all commercially reasonable and diligent efforts to complete Research but in no event shall LKS be obligated to provide research funding or perform Research beyond that funded by RBS and/or as set forth in Section 5.7.2.
Conduct of Research Collaboration. Each Party:
3.6.1. shall use Commercially Reasonable Efforts to conduct its responsibilities under the Work Plan, as assigned to it under each Project Plan, and to achieve the objectives and timelines set forth in the Work Plan, provided that, should either Party foresee any material changes to the timelines or R&D Budget, such Party should promptly notify the other Party; 3.
Conduct of Research Collaboration
